207 related articles for article (PubMed ID: 9498940)
1. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[TBL] [Abstract][Full Text] [Related]
2. Proventil HFA and ventolin have similar safety profiles during regular use.
Tinkelman DG; Bleecker ER; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):290-6. PubMed ID: 9498941
[TBL] [Abstract][Full Text] [Related]
3. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
[TBL] [Abstract][Full Text] [Related]
4. Safety of long-term treatment with HFA albuterol.
Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
6. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
[TBL] [Abstract][Full Text] [Related]
8. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
Shapiro GS; Klinger NM; Ekholm BP; Colice GL
J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
[TBL] [Abstract][Full Text] [Related]
9. Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma.
Shapiro G; Bronsky E; Murray A; Barnhart F; VanderMeer A; Reisner C
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1219-25. PubMed ID: 11115306
[TBL] [Abstract][Full Text] [Related]
10. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
[TBL] [Abstract][Full Text] [Related]
11. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
Welch M; Bernstein D; Gross G; Kane RE; Banerji D
Chest; 1999 Nov; 116(5):1304-12. PubMed ID: 10559092
[TBL] [Abstract][Full Text] [Related]
13. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
14. Equivalence of salbutamol 200 microg four times daily propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. Eastern European study group.
Salat D; Popov D; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S22-8. PubMed ID: 10919682
[TBL] [Abstract][Full Text] [Related]
15. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
[TBL] [Abstract][Full Text] [Related]
16. Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study Group.
Baumgarten CR; Dorow P; Weber HH; Gebhardt R; Kettner J; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S17-21. PubMed ID: 10919681
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
Shin HW; Barletta B; Yoonessi L; Meinardi S; Leu SY; Radom-Aizik S; Randhawa I; Nussbaum E; Blake DR; Cooper DM
Clin Transl Sci; 2015 Oct; 8(5):445-50. PubMed ID: 26155923
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF; Wise R; Busse WW; Garfinkel S; Zubek VB; Ghafouri M; Manuel RC; Schlenker-Herceg R; Bleecker ER
BMC Pulm Med; 2016 Apr; 16(1):65. PubMed ID: 27130202
[TBL] [Abstract][Full Text] [Related]
20. Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma.
Gross G; Cohen RM; Guy H
J Asthma; 2003; 40(5):487-95. PubMed ID: 14529098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
